Nelson, Maxine R. http://orcid.org/0000-0003-1990-5099
Liu, Peng
Agrawal, Ayushi http://orcid.org/0000-0003-2940-8926
Yip, Oscar http://orcid.org/0000-0001-9096-7167
Blumenfeld, Jessica
Traglia, Michela
Kim, Min Joo
Koutsodendris, Nicole http://orcid.org/0000-0002-2761-1480
Rao, Antara http://orcid.org/0000-0002-1269-018X
Grone, Brian
Hao, Yanxia
Yoon, Seo Yeon
Xu, Qin
De Leon, Samuel
Choenyi, Tenzing
Thomas, Reuben
Lopera, Francisco http://orcid.org/0000-0003-3986-1484
Quiroz, Yakeel T. http://orcid.org/0000-0001-9714-8244
Arboleda-Velasquez, Joseph F.
Reiman, Eric M. http://orcid.org/0000-0002-0705-3696
Mahley, Robert W.
Huang, Yadong http://orcid.org/0000-0002-5871-4589
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Aging (R01AG071697, RF1AG076647, P01AG073082, F31AG074690, F31AG074672, P3AG072980, RF1AG059751)
Article History
Received: 23 October 2022
Accepted: 4 October 2023
First Online: 13 November 2023
Competing interests
: Y. Huang and R.W.M. are involved in establishing and managing GABAeron, Inc. Q.X. works part time at GABAeron, Inc. J.F.A.-V. is a co-inventor on a patent application describing methods and compositions for the treatment of Alzheimer’s disease via APOE Christchurch. Other authors declare no competing financial interests.